Medicine and Dentistry
Patient
100%
Surgery
83%
Non Small Cell Lung Cancer
83%
Combination Therapy
50%
Age
50%
Diseases
50%
Neoplasm
33%
Therapeutic Procedure
33%
Lymph Node Metastasis
33%
Overall Survival
33%
Survival Rate
33%
Lung Metastasis
33%
Inpatient
16%
Biological Product
16%
Lymph Node
16%
Multivariate Analysis
16%
Prognostic Factor
16%
Clinical Feature
16%
Cancer Staging
16%
Disease
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
83%
Diseases
66%
Survival Rate
33%
Neoplasm
33%
Lymph Node Metastasis
33%
Overall Survival
33%
Lung Metastasis
33%
Clinical Feature
16%
Biological Product
16%
Cancer Staging
16%
Biochemistry, Genetics and Molecular Biology
Age
50%
Survival Rate
33%
Tumor Volume
33%
Overall Survival
33%
Classification
16%
Multivariate Analysis
16%
Cancer Staging
16%
Neuroscience
Metastasis
66%
Lymph Node
50%